Wolverine Trading’s Guardant Health GH Stock Holding History

Wolverine Trading’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-17,022	Closed	-$479K	–	5473
2024 Q3	$389K	Sell	17,022 -54,978	-76%	-$1.56M	﹤0.01%	3316
2024 Q2	$2.08M	Buy	72,000 +58,684	+441%	+$1.37M	﹤0.01%	1583
2024 Q1	$275K	Buy	+13,316	New	+$285K	﹤0.01%	3462
2022 Q4	–	Sell	-14,916	Closed	-$683K	–	4354
2022 Q3	$801K	Buy	14,916 +10,097	+210%	+$518K	﹤0.01%	2161
2022 Q2	$203K	Sell	4,819 -3,191	-40%	-$158K	﹤0.01%	3538
2022 Q1	$537K	Sell	8,010 -1,251	-14%	-$85.6K	﹤0.01%	3137
2021 Q4	$928K	Buy	+9,261	New	+$958K	﹤0.01%	2720

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wolverine Trading's GH Position: Q4 2024 in Review

Wolverine Trading sold out of Guardant Health (GH) in Q4 2024, closing a stake of 17,022 shares — an estimated $479K sold.

Wolverine Trading first reported a position in GH in Q4 2021 and held it in 7 quarters. The position peaked at $2.08M in Q2 2024. 298 funds tracked by Wall St. Rank hold GH as of Q4 2024.

Wolverine Trading reported no remaining Guardant Health position as of Q4 2024 after selling out during the quarter.
Wolverine Trading sold 17,022 Guardant Health shares in Q4 2024, an estimated $479K.
Wolverine Trading first reported a position in Guardant Health in Q4 2021 and held it in 7 quarters.
Wolverine Trading's Guardant Health position peaked at $2.08M in Q2 2024.
298 funds tracked by Wall St. Rank held Guardant Health as of Q4 2024.

Based on Wolverine Trading's 13F filing for Q4 2024, filed 14 Feb 2025.